Abiopharma

News list

Benesch Joseph 🟢 acquired 70.8K shares (1 derivative) of Journey Medical Corp (DERM) at $5.04 Transaction Date: Apr 22, 2026 | Filing ID: 048733

Full text

News bot April 24, 2026, 9:29 p.m.
🔍 Benesch Joseph (Executive)

Company: Journey Medical Corp (DERM)

Report Date: 2026-04-22
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 70,767
Detailed Transactions and Holdings:
- Acquired 28,907 shares of Common Stock, $0.0001 par value (Direct)
  Date: 2026-04-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 261,371.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Acquired 41,860 shares of Stock Option (Right to Buy) at $5.04 per share (Derivative)
  Date: 2026-04-22 | Code: A | Expires: 2036-04-22 | equity_swap_involved: 0 | shares_owned_after: 41,860.00 | transaction_form_type: 4 | Footnotes: F3
Footnotes:
- F1: On April 22, 2026, the reporting person was granted 28,907 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 9,636 shares on April 22, 2027, 9,636 shares on April 22, 2028 and 9,635 shares on April 22, 2029.
- F2: Includes restricted stock units, which vest over various time periods.
- F3: On April 22, 2026, the reporting person was granted 41,860 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 13,953 shares on April 22, 2027, 13,953 shares on April 22, 2028 and 13,954 shares on April 22, 2029.